1. Home
  2. FPI vs FULC Comparison

FPI vs FULC Comparison

Compare FPI & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.83

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$12.05

Market Cap

468.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
FULC
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
468.1M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
FPI
FULC
Price
$9.83
$12.05
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$16.38
AVG Volume (30 Days)
581.6K
2.6M
Earning Date
10-29-2025
10-29-2025
Dividend Yield
2.45%
N/A
EPS Growth
296.76
N/A
EPS
1.27
N/A
Revenue
$52,990,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.67
N/A
Revenue Growth
N/A
2752.05
52 Week Low
$9.37
$2.32
52 Week High
$12.87
$15.74

Technical Indicators

Market Signals
Indicator
FPI
FULC
Relative Strength Index (RSI) 44.44 53.87
Support Level $9.73 $11.71
Resistance Level $10.53 $12.90
Average True Range (ATR) 0.15 1.16
MACD -0.02 -0.12
Stochastic Oscillator 13.75 47.54

Price Performance

Historical Comparison
FPI
FULC

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: